Theres no easy answer for how to solve the opioid crisis that has cost the U.S. over $37 billion since 2000.
But Robert Kramer, the CEO of Emergent Biosolutions, a biopharmaceutical company responsible for overdose reversal drug Naloxone, laid out three area…
Read More
US opioid crisis: ‘A lot needs to be done’ in 3 key areas – Yahoo Finance
